Novavax Inc on Thursday started a late-stage trial of its experimental COVID-19 vaccine in the United Kingdom in partnership with the government's Vaccines Taskforce, sending the company's shares up 6% after the bell.
FILE PHOTO: A woman holds a small bottle labeled with a"Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration//File Photo
The study is expected to enroll up to 10,000 participants aged between 18 and 84 years and comes after the vaccine candidate produced high levels of antibodies against the novel coronavirus in a small, early-stage clinical trial. The trial will enroll at least 25% of participants over the age of 65 and prioritize groups most affected by the COVID-19, the company said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New COVID-19 Rules Won’t Impact U.K. Production, Exhibition But Optics Aren’t IdealA worrying surge in COVID-19 cases in the U.K. has threatened to unravel much of the progress made across the film and TV industry in recent months, but Prime Minister Boris Johnson’s latest round …
Read more »
UK mulling vaccine trials that deliberately expose volunteers to Covid-19The British government is exploring the possibility of clinical trials in which volunteers are deliberately exposed to coronavirus to test the effectiveness of vaccine candidates, the UK Department for Business, Energy, and Industrial Strategy has revealed
Read more »
Less than 10,000 getting COVID-19 each day, UK health minister saysThe British government estimates less than 10,000 people a day are contracting COVID-19, health minister Matt Hancock said on Thursday, less than during the pandemic's peak, even as numbers testing positive have risen to similar levels.
Read more »
Johnson & Johnson’s Single-Shot COVID-19 Vaccine Moves to Final Trial StageJohnson & Johnson’s vaccine candidate boasts two major advantages over competitors already in Phase 3 trials: It only requires one shot, not two; and it does not need to be stored in subzero temperatures
Read more »
Fourth COVID-19 Vaccine Starts Late Stage TestingJ&J’s COVID-19 Vaccine Will Enter Phase 3 Testing, the Fourth To Reach That Stage
Read more »